Navigation Links
Combined Insurance: Consider Supplemental Accident Insurance and Disability Insurance During Safety Awareness Month
Date:6/26/2008

Safety Awareness Month an Ideal Time to Take Stock of Supplemental Insurance Protection

Chicago, IL (PRWEB) June 26, 2008 -- Combined Insurance, a leading provider of supplemental insurance, encourages consumers to use Safety Awareness Month in June as a good time to ensure they have the right supplemental insurance protection in place to meet their needs should an unplanned accident or illness strike. Owning supplemental accident insurance or disability insurance policies are among the ways consumers can help safeguard individual or family assets in the event an unplanned accident or injury prevents or limits the ability to work.

According to Combined Insurance's research of more than 330,000 accident claims, the most reported accidents in the past year were sprains, fractures and strains totaling more than 200,000 claims. Such injuries can often require medical attention and leave people unable to work for a period of time.

Overall in 2006, there were approximately 3.9 million nonfatal occupational injuries, according to the 2006 Bureau of Labor Statistics, U.S. Department of Labor. In addition, the 2005 edition of Facts and Figures published by the Healthcare Cost and Utilization Project reports the average length of a hospital stay is 5 days, at an average of $22,300 per stay. Such expenses related to hospitalization and emergency-room care can end up costing a family months' worth of income, yet many families
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4 5

Related medicine news :

1. Study Finds New Version of QIAGENs HPV Test for Developing Countries Could Reduce Risk of Cervical Cancer by More than Half When Combined With Appropriate Treatment
2. Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma
3. Combined Boards Provide Better Care to More Clients More Efficiently
4. Combined HRT increases risk of lobular breast cancer fourfold after just 3 years of use
5. Combined radiation seed, chemotherapy wafer implants show promise in treating cancerous brain tumors
6. AT4 wireless and Ekahau Partner to Deploy Combined Asset and Staff Tracking Solution for Hospitals
7. Combined stenting and photodynamic therapy improves survival in late stage liver cancer patients
8. USC researchers find benefit for lymphoma patients in combined PET-CT scanning
9. Home Oxygen Leaders Warn That Competitive Bidding Program Reductions Combined with Other Pending and Proposed Cuts Are Unsustainable and Unpredictable
10. Combined physical and genetic map finds cancers ignition key
11. Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Combined Insurance: Consider Supplemental Accident Insurance and Disability Insurance During Safety Awareness Month
Combined Insurance: Consider Supplemental Accident Insurance and Disability Insurance During Safety Awareness Month
Breaking Medicine Technology:Ascension Orthopedics Hires Key Senior Executives 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 1DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 2DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 3Gene Data Tool Advances Prospects for Personalized Medicine 59221 1Gene Data Tool Advances Prospects for Personalized Medicine 59221 2Gene Data Tool Advances Prospects for Personalized Medicine 59221 3Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 1Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 2Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 3